First-in-class novel recombinant engineered Factor Va Targeted to restore normal clotting Interception of Protein C mediated Factor Va degradation Rapid restoration of Factor V activity during bleeding 3 Activated Protein C cleavage site mutations + +Interdomain Disulfide bond for stability Excellent efficacy. Rapid clearance. Low unwanted effects.
